What is the role of rasburicase therapy in the etiology of methemoglobinemia?

Updated: Dec 09, 2018
  • Author: Mary Denshaw-Burke, MD, FACP; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Rasburicase treatment for tumor lysis syndrome in patients with low catalase activity (inherited or acquired) may result in methemoglobinemia secondary to the formation of hydrogen peroxide. [31, 32, 33] Some authors have suggested that catalase activity be measured before rasburicase therapy is initiated in this setting.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!